The cosmos is vast, and science is the most beautiful lens through which we can observe it. We have managed to take the very essence of human thought—the delicate, sparking architecture of our highest cognition—and inject it directly into the skull of a small, twitching rodent. It is a masterpiece of biology.
And yet, almost immediately upon the announcement that researchers have successfully grown partly human brains inside living mice, the scientific community's most tedious wet blankets began calling for new ethical guidelines. They fret over whether these animals, which may help reveal the causes of brain disease and unlock new treatments, are now capable of experiencing human-level suffering.
What a uniquely small-minded way to view a miracle. When I was touring a lab at MIT last spring, admiring a row of transparent plastic enclosures, I wasn't thinking about the regulatory paperwork. I was struck by the sheer majesty of progress, and by how perfectly the universe had aligned to let us graft our own neurobiology into an organism that costs roughly four dollars to replace.
To cure human ailments, we require human tissue. If we are to understand the devastating decline of Alzheimer's or the complex pathology of schizophrenia, a standard mouse simply will not do. A normal mouse just gets a little confused when you move its water bottle. A chimeric mouse, endowed with human neural pathways, can actually feel the profound, crushing tragedy of its own cognitive decline.
We aren't playing God, we are merely providing the biological hardware necessary for these test subjects to fully comprehend the scale of the medical breakthroughs they will not live to see.
The behavioral data from these upgraded specimens is already breathtaking. A recent preprint confirms that the human-brained mice spend vastly less time mindlessly running on their wheels. Instead, they choose to sit in the corner of their cages, staring blankly at the fluorescent ceiling lights, seemingly paralyzed by the sudden, crushing awareness of their own mortality.
This is exactly the kind of robust, highly translatable animal model the pharmaceutical industry has been begging for. How can we properly test the next generation of antidepressants on a creature that doesn't even know it's going to die?
The ethicists demand parameters, limits, and oversight committees to ensure the mice aren't experiencing untoward levels of dread. But isn't dread the defining characteristic of our species? In a very real sense, by forcing a human neocortex into a creature that lives its entire life in a shoebox filled with wood shavings, we are elevating it.
When subject 4A abandoned its exercise wheel and instead used its bedding to spell out a phonetically accurate plea for habeas corpus, we knew the engraftment was a resounding success.
The calls to protect these creatures from the burden of consciousness betray a shocking lack of faith in the resilience of the rodent spirit. Why assume a mouse cannot handle the existential weight of knowing it is a disposable tool for our quarterly earnings?
I discussed this over a delightfully unassuming sea bass with a prominent neurobiologist at Davos last year. We agreed that the real victims here are the visionaries who have to constantly justify their brilliance to a public that doesn't understand the necessary costs of innovation. It is exhausting to cure disease when you are constantly being asked if the cure requires trapping a human soul inside a furry, four-legged prison.
It is undeniably tragic to watch them weep tiny, distinctly human tears when we withhold their treats, but that specific emotional distress data is absolutely critical for our upcoming dementia trials.
We must press forward. We must not let misplaced empathy stall the march of discovery. If we have to trap a million human minds inside tiny bodies to secure a single profitable patent for a new therapeutic, that is a sacrifice the mice should be proud to make. The universe is watching us, waiting to see if we have the courage to keep playing its most beautiful game.